Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

While overall risk of macular degeneration remained low, a study suggests that GLP-1 drugs may have increased that risk in ...

Diabetes and thyroid disorders often go hand-in-hand, impacting how your body uses energy and controls blood sugar. In India, ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Boyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, ...

Dr. Lessieur-Contreras will continue her groundbreaking research on understanding the early stages of diabetic retinopathy ...

Cataracts are a common reason for blurry vision, especially as we age. But eye experts say other serious conditions like ...

A comprehensive eye exam in a crowded doctor’s office can often take the better part of two hours, with much of that time ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

The integration of artificial intelligence (AI) into fundus cameras presents a significant opportunity for market growth. AI algorithms demonstrate high accuracy in detecting diseases like diabetic ...

It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or an expected side effect of this weight loss drug. However, if you are on ...

Lake Oswego, Oregon – As advancements in laser eye surgery continue to expand access to vision correction, individuals with ...